(Q37813409)

23 August 2017

1 reference

title

Metabolic syndrome, insulin resistance, and chronic allograft dysfunction (English)

1 reference

23 August 2017

1 reference

1 reference

1 reference

1

Esteban Porrini

1 reference

23 August 2017

Patricia Delgado

2

1 reference

PubMed ID

21116317

23 August 2017

Armando Torres

series ordinal

3

1 reference

23 August 2017

1 December 2010

1 reference

Kidney International. Supplement

23 August 2017

1 reference

23 August 2017

119

1 reference

23 August 2017

S42-6

1 reference

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

23 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Association between C-reactive protein and features of the metabolic syndrome: a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Hyperinsulinemia cluster predicts the development of type 2 diabetes independently of family history of diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Chronic renal allograft rejection: pathophysiologic considerations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin resistance as putative cause of chronic renal transplant dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Kidney pathological changes in metabolic syndrome: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Chronic graft rejection: accelerated transplant arteriosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin resistance and insulin deficiency in the pathogenesis of posttransplantation diabetes in man

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Prediabetes in patients receiving tacrolimus in the first year after kidney transplantation: a prospective and multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Unmasking glucose metabolism alterations in stable renal transplant recipients: a multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Metabolic syndrome after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Determinants of insulin resistance in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Hypoadiponectinemia is associated with insulin resistance and glucose intolerance after renal transplantation: impact of immunosuppressive and antihypertensive drug therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Glucose control by the kidney: an emerging target in diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Achieving chronic kidney disease treatment targets in renal transplant recipients: results from a cross-sectional study in Spain.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin resistance: a chicken that has come to roost

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin resistance and risk of chronic kidney disease in nondiabetic US adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin resistance and salt-sensitive hypertension in metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Insulin induces renal vasodilation, increases plasma renin activity, and sensitizes the renal vasculature to angiotensin receptor blockade in healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2010.422

1 reference

7 January 2021

Glomerular hyperfiltration: a new marker of metabolic risk.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Donor kidney volume and outcomes following live donor kidney transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Inadequate donor size in cadaver kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Body mass index and glomerular hyperfiltration in renal transplant recipients: cross-sectional analysis and long-term impact

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Hyperinsulinemia and hyperfiltration in renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

C-reactive protein and body mass index independently predict mortality in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Glycated haemoglobin levels are related to chronic subclinical inflammation in renal transplant recipients without pre-existing or new onset diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Carotid atheromatosis in nondiabetic renal transplant recipients: the role of prediabetic glucose homeostasis alterations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Metabolic syndrome and atherosclerotic events in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Validation of insulin resistance indexes in a stable renal transplant population.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.422

7 January 2021

Identifiers

DOI

10.1038/KI.2010.422

1 reference

23 August 2017

1 reference

PubMed ID

21116317